Jpmorgan Chase & CO Reviva Pharmaceuticals Holdings, Inc. Put Options Transaction History
Jpmorgan Chase & CO
- $1.23 Trillion
- Q4 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding RVPH
# of Institutions
50Shares Held
7.84MCall Options Held
628KPut Options Held
338K-
Israel Englander Millennium Management LLC | New York, Ny1.8MShares$1.53 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.38MShares$1.18 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY1.36MShares$1.16 Million0.03% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY1.06MShares$899,3850.01% of portfolio
-
Parkman Healthcare Partners LLC Stamford, CT514KShares$437,1320.13% of portfolio
About REVIVA PHARMACEUTICALS HOLDINGS, INC.
- Ticker RVPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,442,900
- Market Cap $17.4M
- Description
- Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is RP506...